发明名称 HYDROXAMIC ACID DERIVATIVES, PROCESS FOR THEIR PREPARATION AND USE THEREOF
摘要 Compounds of general formula I: <CHEM> Wherein : R<1> is hydrogen, C1 - C6 alkyl, phenyl, substituted phenyl, phenyl(C1 - C6 alkyl), or heterocyclyl; or R<1> is ASOnR<7> wherein A represents a C1 - C6 hydrocarbon chain, optionally substituted with one or more C1 - C6 alkyl, phenyl or substituted phenyl groups n = 0,1,2; R<7> is C1 - C6 alkyl, phenyl, substituted phenyl, phenyl (C1-C6 alkyl), heterocyclyl, (C1 - C6 alkyl)acyl thienyl or phenacyl; R<2> is hydrogen, C1 - C6 alkyl, C2 - C6 alkenyl, phenyl (C1 - C6alkyl) or cycloalkyl(C1 - C6 alkyl); R<3> and R<4> are selected from hydrogen, halogen, cyano amino, amino(C1 - C6)alkyl, amino di(C1 - C6)alkyl, amino(C1 - C6)alkylacyl, aminophenacyl, amino (substituted) phenacyl, amino acid or derivative thereof, hydroxy, oxy(C1 - C6)alkyl, oxyacyl, formyl, carboxylic acid, carboxamide, carboxy(C1 - C6) alkylamide, carboxyphenylamide, carboxy(C1 - C6) alkyl, hydroxy(C1 - C6)alkyl, (C1 - C6)alkyloxy(C1 - C6) alkyl or acyloxy(C1 - C6)alkyl, (C1 - C6)alkylcarboxylic acid, (C1-C6) alkylcarboxy(C1 - C6) alkyl, amino (C1-6)alkylacyl carboxylic acid or amino (C1-6)alkylacyl (C1-6) alkylcarboxylate; or R<3> is OCH2COR<8> R<4> is hydrogen; wherein R<8> is hydroxyl, C1 - C6 oxyalkyl, C1 - C6 oxyalkylphenyl, amino, C1 - C6 aminoalkyl, C1 - C6 aminodialkyl; C1 - C6 aminoalkylphenyl, an amino acid or derivative thereof; or R<3> is OCH2CH2OR<9> and R<4> is hydrogen; wherein R<9> is C1 - C6 alkyl, C1 - C6 alkylphenyl, phenyl, substituted phenyl, (C1 - C6 alkyl)acyl, or phenacyl; or R<3> is OCH2CN and R<4> is hydrogen; R<5> is hydrogen or C1 - C6 alkyl, or (C1 - C6) alkylphenyl; R<6> is hydrogen or methyl; or a salt thereof; specifically excluded are compounds wherein: R<3> = R<4> = hydrogen or R<3> = R<4> = hydroxy or R<3> = hydrogen and R<4> = oxybenzyl or R<3> = hydrogen and R<4> = oxy(C1 - C6 alkyl); or a salt thereof; have collagenase inhibition activity and are useful in the management of disease involving collagen degradation. Its uses include rheumatoide arthritis, corneal ulceration, osteoporosis, periodontitis, gingivitis and tumour invasion.
申请公布号 AU1194492(A) 申请公布日期 1992.09.07
申请号 AU19920011944 申请日期 1992.02.07
申请人 BRITISH BIO-TECHNOLOGY LIMITED 发明人 MICHAEL JOHN CRIMMIN;ALAN HORNSBY DAVIDSON;RAYMOND PAUL BECKETT
分类号 A61K31/165;A61K31/19;A61K31/215;A61K31/275;A61K31/38;A61K31/381;A61P1/02;A61P19/10;A61P27/02;A61P29/00;A61P43/00;C07C237/22;C07C259/06;C07C323/60;C07D333/34 主分类号 A61K31/165
代理机构 代理人
主权项
地址